Deep-pocketed investors have adopted a bullish approach towards Moderna (NASDAQ:MRNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRNA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 32 extraordinary options activities for Moderna. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 43% leaning bullish and 37% bearish. Among these notable options, 7 are puts, totaling $556,704, and 25 are calls, amounting to $2,114,502.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $180.0 for Moderna over the recent three months.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $90.0 to $180.0 in the last 30 days.
Moderna Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | CALL | TRADE | NEUTRAL | 01/17/25 | $46.95 | $42.7 | $44.85 | $130.00 | $358.8K | 1.3K | 80 |
MRNA | PUT | TRADE | BEARISH | 01/17/25 | $14.7 | $14.4 | $14.7 | $140.00 | $294.0K | 428 | 1 |
MRNA | CALL | SWEEP | BULLISH | 01/16/26 | $75.3 | $68.2 | $72.73 | $110.00 | $290.8K | 168 | 40 |
MRNA | CALL | SWEEP | NEUTRAL | 05/31/24 | $21.7 | $20.45 | $21.05 | $140.00 | $210.5K | 693 | 101 |
MRNA | CALL | TRADE | NEUTRAL | 01/16/26 | $49.9 | $43.75 | $47.37 | $160.00 | $189.4K | 455 | 0 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Moderna's Current Market Status
- With a volume of 1,393,780, the price of MRNA is down -2.28% at $159.61.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 70 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
財力雄厚的投資者對Moderna(NASDAQ:MRNA)採取了看漲態度,這是市場參與者不容忽視的。我們對本辛加公開期權記錄的追蹤今天揭示了這一重大舉措。這些投資者的身份仍然未知,但是MRNA的如此重大變動通常表明即將發生重大事件。
我們今天從觀察中收集了這些信息,當時Benzinga的期權掃描儀重點介紹了Moderna的32項非同尋常的期權活動。這種活動水平與衆不同。
這些重量級投資者的總體情緒存在分歧,43%的人傾向於看漲,37%的人傾向於看跌。在這些值得注意的期權中,有7個是看跌期權,總額爲556,704美元,25個是看漲期權,總額爲2,114,502美元。
目標價格是多少?
根據交易活動,看來主要投資者的目標是在最近三個月中將Moderna的價格範圍從90.0美元擴大到180.0美元。
交易量和未平倉合約趨勢
在交易期權時,查看交易量和未平倉合約是一個強有力的舉動。這些數據可以幫助您跟蹤給定行使價下Moderna期權的流動性和利息。下面,我們可以分別觀察過去30天中Moderna所有鯨魚交易的看漲期權和看跌期權交易量和未平倉合約的變化,其行使價在90.0美元至180.0美元之間。
Moderna 期權活動分析:過去 30 天
發現的最大選擇:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | CALL | TRADE | NEUTRAL | 01/17/25 | $46.95 | $42.7 | $44.85 | $130.00 | $358.8K | 1.3K | 80 |
MRNA | PUT | TRADE | BEARISH | 01/17/25 | $14.7 | $14.4 | $14.7 | $140.00 | $294.0K | 428 | 1 |
MRNA | CALL | SWEEP | BULLISH | 01/16/26 | $75.3 | $68.2 | $72.73 | $110.00 | $290.8K | 168 | 40 |
MRNA | CALL | SWEEP | NEUTRAL | 05/31/24 | $21.7 | $20.45 | $21.05 | $140.00 | $210.5K | 693 | 101 |
MRNA | CALL | TRADE | NEUTRAL | 01/16/26 | $49.9 | $43.75 | $47.37 | $160.00 | $189.4K | 455 | 0 |
關於 Moderna
Moderna是一家商業階段的生物技術公司,成立於2010年,並於2018年12月進行了首次公開募股。該公司的 mRNA 技術通過其 COVID-19 疫苗迅速得到驗證,該疫苗於 2020 年 12 月在美國獲得授權。截至2023年中期,Moderna在臨床試驗中有39個mRNA開發候選藥物。項目涵蓋廣泛的治療領域,包括傳染病、腫瘤學、心血管疾病和罕見遺傳病。
鑑於Moderna最近的期權歷史,現在應該專注於公司本身。我們的目標是探索其目前的表現。
Moderna 的當前市場狀況
與僅交易股票相比,期權是一種風險更高的資產,但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。